Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cano JM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 38
Tytuł:
Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case–control study (CONSISTE study)
Autorzy:
de Lucas-Ramos P
Izquierdo-Alonso JL
Rodriguez Gonzalez-Moro JM
Fernandez Frances J
Vaquero Lozano P
Bellón-Cano JM
Pokaż więcej
Temat:
Diseases of the respiratory system
RC705-779
Źródło:
International Journal of COPD, Vol 2012, Iss default, Pp 679-686 (2012)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/chronic-obstructive-pulmonary-disease-as-a-cardiovascular-risk-factor--a11158; https://doaj.org/toc/1176-9106; https://doaj.org/toc/1178-2005
Dostęp URL:
https://doaj.org/article/a71a08b5991e4c6c914b653aec9ccbc2  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy of [ Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Autorzy:
Mitjavila M; Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Jimenez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Belló P; Department of Nuclear Medicine, Hospital Universitario La Fe, Valencia, Spain.
Pubul V; Department of Nuclear Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Percovich JC; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Garcia-Burillo A; Department of Nuclear Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Hernando J; Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Arbizu J; Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
Rodeño E; Department of Nuclear Medicine, Hospital Universitario de Cruces, Bilbao, Spain.
Estorch M; Department of Nuclear Medicine, Hospital de la Santa Creu i San Pau, Barcelona, Spain.
Llana B; Department of Nuclear Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
Castellón M; Department of Nuclear Medicine, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
García-Cañamaque L; Department of Nuclear Medicine, Hospital HM Sanchinarro, Madrid, Spain.
Gajate P; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Riesco MC; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Miguel MB; Department of Nuclear Medicine, Hospital Universitario de Burgos, Burgos, Spain.
Balaguer-Muñoz D; Department of Nuclear Medicine, Hospital Universitario Doctor Peset, Valencia, Spain.
Custodio A; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
Cano JM; Department of Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
Repetto A; Department of Nuclear Medicine, Hospital Universitario Son Espases, Mallorca, Spain.
Garcia-Alonso P; Department of Nuclear Medicine, Hospital Universitario de Getafe, Madrid, Spain.
Muros MA; Department of Nuclear Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Vercher-Conejero JL; Department of Nuclear Medicine-PET Unit, Hospital Universitario de Bellvitge - IDIBELL, Barcelona, Spain.
Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, University de Murcia, IMIB, Murcia, Spain. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2486-2500. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroendocrine Tumors*/pathology
Pheochromocytoma*
Paraganglioma*
Adrenal Gland Neoplasms*
Organometallic Compounds*/adverse effects
Humans ; Octreotide/adverse effects ; Prognosis ; Receptors, Somatostatin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer.
Autorzy:
Rodriguez-Gonzalez A; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Hernández R; Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain.
Cruz-Castellanos P; Department of Oncology Medical. Hospital, Universitario La Paz, Madrid, Spain.
Fernández-Montes A; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense - CHUO, Orense, Spain.
Castillo-Trujillo O; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Muñoz MM; Department of Medical Oncology, Hospital General Virgen de La Luz, Cuenca, Spain.
Cano-Cano JM; Department of Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
Corral MJ; Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain.
Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Jiménez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Calderon C; Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain. .
Pokaż więcej
Źródło:
Health and quality of life outcomes [Health Qual Life Outcomes] 2023 Feb 17; Vol. 21 (1), pp. 15. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Colorectal Neoplasms*/psychology
Psychological Distress*
Humans ; Quality of Life ; Prospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lung Ultrasound as a Triage Method in Primary Care for Patients with Suspected SARS-CoV-2 Pneumonia.
Autorzy:
Guzmán-García MB; Primary Care, Health Service (SESCAM), 13500 Puertollano, Ciudad Real, Spain.
Mohedano-Moriano A; Department of Medical Sciences, Faculty of Health Sciences, Castilla-La Mancha University, 45600 Talavera de la Reina, Toledo, Spain.
González-González J; Department of Medical Sciences, Faculty of Health Sciences, Castilla-La Mancha University, 45600 Talavera de la Reina, Toledo, Spain.; Integrated Attention Management of Talavera de la Reina, Castilla-La Mancha Health Service (SESCAM), 45600 Talavera de la Reina, Toledo, Spain.
Morales-Cano JM; Primary Care, Health Service (SESCAM), 13005 Ciudad Real, Spain.
Campo-Linares R; Emergency Department, Health Service (SESCAM), 13500 Puertollano, Ciudad Real, Spain.
Lozano-Suárez C; Primary Care, Health Service (SESCAM), 13005 Ciudad Real, Spain.
Estrada-Álvarez TP; Department of Gynecology and Obstetrics, Health Service (SESCAM), 13005 Ciudad Real, Spain.
Romero-Fernández MM; Coordinator of the Research, Teaching and Library Unit, Puertollano Hospital, Health Service (SESCAM), 13500 Puertollano, Ciudad Real, Spain.
Aguilar-Galán EV; Department of Gynecology and Obstetrics, Health Service (SESCAM), 41007 Toledo, Spain.
Criado-Álvarez JJ; Department of Medical Sciences, Faculty of Health Sciences, Castilla-La Mancha University, 45600 Talavera de la Reina, Toledo, Spain.; Institute of Health Sciences of Castilla-La Mancha, 45600 Talavera de la Reina, Toledo, Spain.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Oct 29; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility.
Autorzy:
Marchena-Perea EM; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Salazar-Hidalgo ME; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Gómez-Sanz A; Molecular Oncology Laboratory (CIBERONC), Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
Arranz-Ledo M; Cancer Genetics Group, Unidad de Excelencia Instituto de Biología y Genética Molecular, Universidad de Valladolid-Consejo Superior de Investigaciones Científicas (IBGM, UVa-CSIC), 47003 Valladolid, Spain.
Barroso A; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Fernández V; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Tejera-Pérez H; Human Cancer Genetics Programme, Human Genotyping Unit (CEGEN), Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Pita G; Human Cancer Genetics Programme, Human Genotyping Unit (CEGEN), Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Núñez-Torres R; Human Cancer Genetics Programme, Human Genotyping Unit (CEGEN), Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Pombo L; Medical Oncology Section, Universitary Hospital Complex of Albacete, 02006 Albacete, Spain.
Morales-Chamorro R; Medical Oncology Section, Hospitalary Compex La Mancha Centro, 13600 Alcázar de San Juan, Spain.
Cano-Cano JM; Medical Oncology Service, Universitary General Hospital of Ciudad Real, 13005 Ciudad Real, Spain.
Soriano MDC; Oncology Service, Virgen de la Luz Hospital, 16002 Cuenca, Spain.
Garre P; Molecular Oncology Laboratory (CIBERONC), Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
Durán M; Cancer Genetics Group, Unidad de Excelencia Instituto de Biología y Genética Molecular, Universidad de Valladolid-Consejo Superior de Investigaciones Científicas (IBGM, UVa-CSIC), 47003 Valladolid, Spain.
Currás-Freixes M; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
de la Hoya M; Molecular Oncology Laboratory (CIBERONC), Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
Osorio A; Human Cancer Genetics Programme, Familial Cancer Clinical Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Spanish Network on Rare Diseases (CIBERER), 28029 Madrid, Spain.; Genetics Service, Fundación Jiménez Díaz, 28043 Madrid, Spain.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Sep 28; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants.
Autorzy:
Benito-Sánchez B; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Barroso A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Fernández V; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Mercadillo F; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Núñez-Torres R; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Pita G; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Pombo L; Medical Oncology Section, Universitary Hospital Complex of Albacete, Albacete, Spain.
Morales-Chamorro R; Medical Oncology Section, Hospitalary Compex La Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain.
Cano-Cano JM; Medical Oncology Service, Universitary General Hospital of Ciudad Real, Ciudad Real, Spain.
Urioste M; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
González-Neira A; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. .; Spanish Network On Rare Diseases (CIBERER), 28029, Madrid, Spain. .; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 29029, Madrid, Spain. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 May 20; Vol. 12 (1), pp. 8547. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/genetics
DNA Copy Number Variations*/genetics
Ovarian Neoplasms*/genetics
Tumor Suppressor Proteins*/genetics
Ubiquitin-Protein Ligases*/genetics
BRCA1 Protein/genetics ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Spain/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
Autorzy:
Martínez-Trufero J; Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
De Sande-González LM; Medical Oncology Department, Complejo Asistencial Universitario de Leon, 24008 Leon, Spain.
Luna P; Medical Oncology Department, Hospital Universitario Son Espases, 07010 Palma de Mallorca, Spain.
Martin-Broto J; Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS; CSIC, US, HUVR), 41013 Sevilla, Spain.
Álvarez R; Medical Oncology Department, Hospital Universitario Gregorio Marañon, 28009 Madrid, Spain.
Marquina G; Medical Oncology Department, Hospital Universitario Clinico San Carlos, 28040 Madrid, Spain.
Diaz-Beveridge R; Medical Oncology Department, Hospital Politécnico La Fe, 46026 Valencia, Spain.
Poveda A; Medical Oncology Department, Instituto Valenciano de Oncologia, 46007 Valencia, Spain.
Cano JM; Medical Oncology Department, Hospital General de Ciudad Real, 13005 Ciudad Real, Spain.
Cruz-Jurado J; Medical Oncology Department, Hospital Universitario Canarias, 38320 Santa Cruz de Tenerife, Spain.
López Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, 08001 Barcelona, Spain.
Vaz Salgado MA; Medical Oncology Department, Hospital Universitario Ramon y Cajal, RYCIS, CIBERONC, 28034 Madrid, Spain.
Valverde-Morales CM; Medical Oncology Department, Hospital Universitario Vall D'Hebron, 08035 Barcelona, Spain.
Sevilla I; Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Medical Oncology Department, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, 29010 Malaga, Spain.
Martínez-García J; Medical Oncology Department, Hospital Virgen de la Arrixaca, 30120 Murcia, Spain.
Rubio-Casadevall J; Medical Oncology Department, Instituto Catalan Oncologia, 17007 Girona, Spain.
De Juan A; Medical Oncology Department, Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Carrasco JA; Medical Oncology Department, Hospital Alvaro Cunqueiro, 36213 Vigo, Spain.
Moura DS; Instituto de Biomedicina de Sevilla (IBiS; CSIC, US, HUVR), 41013 Sevilla, Spain.
Gurruchaga-Sotes I; Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Gutiérrez A; Hematology Department, Hospital Universitario Son Espases, 07010 Palma de Mallorca, Spain.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Feb 14; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[Basic knowledge about healthy eating in medical graduates].
Autorzy:
Muñoz Cano JM; División Académica Ciencias de la Salud. Universidad Juárez Autónoma de Tabasco.
Córdova Hernández JA; División Académica Ciencias de la Salud. Universidad Juárez Autónoma de Tabasco.
Guzmán Priego C; División Académica Ciencias de la Salud. Universidad Juárez Autónoma de Tabasco.
Pokaż więcej
Transliterated Title:
Conocimientos básicos sobre alimentación saludable en egresados de medicina.
Źródło:
Nutricion hospitalaria [Nutr Hosp] 2020 Dec 16; Vol. 37 (6), pp. 1226-1231.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Diet, Healthy*
Health Knowledge, Attitudes, Practice*
Chronic Disease/*prevention & control
Physicians/*statistics & numerical data
Adult ; Biochemistry/education ; Cross-Sectional Studies ; Disease Progression ; Female ; Health Promotion ; Humans ; Life Style ; Male ; Mexico ; Nutritional Sciences/education ; Surveys and Questionnaires/statistics & numerical data
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 38

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies